A KRAS-variant as a putative biomarker of ovarian cancer risk

被引：0
|
作者：
Weidhaas, Joanne B.
Slack, Frank
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-1856
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1856
引用
下载
收藏
页数：3
相关论文
共 50 条
  • [41] Association of common WRAP 53 variant with ovarian cancer risk in the Polish population
    Medrek, Krzysztof
    Magnowski, Piotr
    Masojc, Bartlomiej
    Chudecka-Glaz, Anita
    Torbe, Bogdan
    Menkiszak, Janusz
    Spaczynski, Marek
    Gronwald, Jacek
    Lubinski, Jan
    Gorski, Bohdan
    MOLECULAR BIOLOGY REPORTS, 2013, 40 (03) : 2145 - 2147
  • [42] Association of common WRAP 53 variant with ovarian cancer risk in the Polish population
    Krzysztof Mędrek
    Piotr Magnowski
    Bartłomiej Masojć
    Anita Chudecka-Głaz
    Bogdan Torbe
    Janusz Menkiszak
    Marek Spaczyński
    Jacek Gronwald
    Jan Lubiński
    Bohdan Górski
    Molecular Biology Reports, 2013, 40 : 2145 - 2147
  • [43] RETRACTED: A 3′ UTR KRAS variant as a biomarker of poor outcome and chemotherapy resistance in ovarian cancer (Retracted article. See vol. 122, pg. 205, 2011)
    Ratner, E.
    Keane, F.
    Yu, H.
    Zelterman, D.
    Rutherford, T.
    Santin, A.
    Schwartz, P.
    Slack, F.
    Levine, D.
    Weidhaas, J.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S3 - S3
  • [44] CD44 Variant 6 as a Predictive Biomarker for Distant Metastasis in Patients With Epithelial Ovarian Cancer
    Motohara, Takeshi
    Fujimoto, Koichi
    Tayama, Shingo
    Narantuya, Dashdemberel
    Sakaguchi, Isao
    Tashiro, Hironori
    Katabuchi, Hidetaka
    OBSTETRICS AND GYNECOLOGY, 2016, 127 (06): : 1003 - 1011
  • [45] Estrogen withdrawal, breast cell transformation, and multiple breast cancer risk in women with the KRAS-variant.
    Weidhaas, Joanne B.
    McVeigh, Terri Patricia
    Jung, Song Yi
    Salzman, David
    Nallur, Sunitha
    Dookwah, Michelle
    Nemec, Antonia A.
    Sadofsky, Jackie
    Paranjape, Trupti
    Kelly, Olivia
    Chan, Elcie
    Miller, Nicola
    Sweeney, Karl J.
    Zelterman, Daniel
    Sweasy, Joann
    Pilarski, Robert
    Telesca, Donatello
    Kerin, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [46] Biomarker Selection in Early Ovarian Cancer
    O'Lealy, John J.
    O'Kane, Sara
    O'Toole, Sharon
    O'Brien, John K.
    Pennington, Stephen R.
    Cahill, Dolores J.
    MODERN PATHOLOGY, 2016, 29 : 299A - 299A
  • [47] LyGDI is a Promising Biomarker for Ovarian Cancer
    Zhen, Hongying
    Yang, Shaomin
    Wu, Hounan
    Wang, Shuling
    Lv, Jingqiao
    Ma, Lijun
    Zhang, Xiaowei
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (03) : 316 - 322
  • [48] Biomarker Selection in Early Ovarian Cancer
    O'Leary, John J.
    O'Kane, Sara
    O'Toole, Sharon
    O'Brien, John K.
    Pennington, Stephen R.
    Cahill, Dolores J.
    LABORATORY INVESTIGATION, 2016, 96 : 299A - 299A
  • [49] Autoantibody biomarker profiling in ovarian cancer
    Rodriguez, Noah
    Yang, Junzheng
    Choi, Pui-Wah
    Ng, Shu-Kay
    Vitonis, Allison
    Liu, Brian
    Cramer, Daniel
    Berkowitz, Ross
    Ng, Shu-Wing
    CANCER RESEARCH, 2009, 69
  • [50] Serum amyloid a as ovarian cancer biomarker
    Moshkovskii, S.
    Vlasova, M.
    Safarova, M.
    Makarov, O.
    Archakov, A.
    MOLECULAR & CELLULAR PROTEOMICS, 2005, 4 (08) : S122 - S122
12345